Previous business/academic article Next business/academic article
Business Articles Awards > General Antitrust

It Is All About the Facts: Commentary on the Current State of Antitrust Enforcement in Health Care

Leigh L. Oliver, 48 Loyola University Chicago Law Journal, May 2017

See Leigh L. Oliver's resume

Click here to read the full article online

This Essay specifically addresses the conference presentations of Professors Barak Richman and Tim Greaney, but also shares my own
views on the current state of antitrust enforcement in health care, including current challenges and potential reforms.

In summary, both Professors Richman and Greaney seemed critical of the antitrust laws and argued that the antitrust laws failed to prevent the level of concentration that we see in the health care industry today, or that they are poorly suited to regulate anticompetitive conduct related to the pharmaceutical industry. I disagree. Antitrust jurisprudence is an enforcement tool available to state and federal agencies, as well as to private citizens. And agencies and private citizens use these laws in traditional and novel ways to challenge anticompetitive conduct. The outcome of enforcement actions, however, depends in large part on the specific facts and circumstances of each individual case. This is the benefit of the case-based nature of the competition regulation and this approach arguably prevents antitrust laws from having a chilling effect on growth, innovation, and the achievement of economic efficiencies.

Download our brochure